Galderma has announced that it will be launching two pivotal Phase 3 trials focused on its Restylane dermal fillers.
The Restylane Silk Cannula Study is a multicenter trial that will evaluate the safety and tolerability of Restylane Silk when delivered via microcannula.
The Restylane Lyft Hand Rejuvenation Study is a randomized, controlled, multicenter study to assess the safety, tolerability and efficacy of Restylane Lyft for volume loss in the hands.
For more information, visit www.galderma.com.
